Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02660398 · ClinicalTrials.gov registry record · Phase 4
Incidence and Severity of Residual Neuromuscular Blockade
A Phase 4 study, sponsored by University of Washington.
- Completed
- Registry status
- Phase 4
- Development phase
- 78
- Enrollment target
NCT02660398 is a Phase 4 study that has completed, run by University of Washington. The registered enrollment target is 78 participants.
The verdict
NCT02660398, a Phase 4 study, has completed, sponsored by University of Washington.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 78 participants
- Enrollment target
Study Summary
This prospective study will take place at Harborview Medical Center (HMC) and the University of Washington Medical Center (UWMC), and will enroll adult patients undergoing abdominal surgery. The purpose of this study is to identify if the use of a specific plan to managing muscle relaxants will help decrease the risk of muscle weakness after general anesthesia with muscle relaxation in a population of patients undergoing abdominal surgery.
Interventions
- PROCEDURE Standardized NMBD Management
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 78 participants |
| Start Date | 2016-01 |
| Est. Completion | 2017-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02660398
The ClinicalTrials.gov registry entry for NCT02660398 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 78 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Washington, which has 1,048 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Standardized NMBD Management is the first listed.
NCT02660398 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02660398 about?
NCT02660398 is a clinical study titled "Incidence and Severity of Residual Neuromuscular Blockade". This prospective study will take place at Harborview Medical Center (HMC) and the University of Washington Medical Center (UWMC), and will enroll adult patients undergoing abdominal surgery. The purpose of this study is to identify if the use of a specific plan to managing muscle relaxants will help...
What is the current status of trial NCT02660398?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 78 participants. The study started on 2016-01. Estimated completion is 2017-01.
What interventions are being tested in trial NCT02660398?
The interventions under investigation include: Standardized NMBD Management (PROCEDURE).
Who is sponsoring clinical trial NCT02660398?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.